Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Biotech
Big Pharma-backed GlycoEra raises $130M for protein degraders
The cash will primarily go toward initiating clinical trials for GE8820, a bispecific molecule designed to destroy IgG4 autoantibodies.
Darren Incorvaia
May 27, 2025 7:00am
Novo Holdings dials back investment as Trump stumps forecasters
Apr 28, 2025 10:33am
Glycomine's $115M series C to fund genetic disorder ph. 2 plans
Apr 16, 2025 9:20am
Newleos unveils with $93M and 4 ex-Roche programs
Feb 13, 2025 12:00am
Windward generates $200M with Novo Holdings, OrbiMed in tow
Jan 10, 2025 10:02am
Novo Holdings-backed SiteOne charges up with $100M financing
Dec 18, 2024 7:00am
